Skip to content

Rogers Corporation ROG Market capitalization

Market capitalization at other companies

3M logo
3MMMM
$75.87B-4.2%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$2.11B+75.2%
Biogen logo
BiogenBIIB
$26.91B+34.3%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$1.97B+78.5%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$18.73B-40.0%
Entegris logo
EntegrisENTG
$17.85B+34.8%

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0.0×
Current ratio+0.1×

Where this comes from

Computed from the period-end share price: $1.91B.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's market capitalization?
Rogers Corporation (ROG) reported market capitalization of $1.91B in Q1 2026.
How has Rogers Corporation's market capitalization changed year-over-year?
Rogers Corporation's market capitalization increased by 53.1% year-over-year, from $1.25B to $1.91B.
What is the long-term trend for Rogers Corporation's market capitalization?
Over 5 years (2020 to 2025), Rogers Corporation's market capitalization has grown at a -10.8% compound annual growth rate (CAGR), from $2.91B to $1.65B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.